Severance Agreements in the Pharmaceuticals Industry

376 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Jazz Pharmaceuticals plc Executive Committee Severance Benefit Plan (Effective April 23, 2025)
Severance Agreements
Jazz Pharmaceuticals plc
Pharmaceuticals
CA
2025
Bristol-Myers Squibb Company Severance Benefits Plan and Summary Plan Description
Severance Agreements
Bristol-Myers Squibb
Pharmaceuticals
NJ
2025
Severance Rights Agreement between Inmagene Biopharmaceuticals and Erin Butler
Severance Agreements
Ikena Oncology, Inc.
Pharmaceuticals
CA
2025
Severance Rights Agreement between Inmagene Biopharmaceuticals and Yufang Lu
Severance Agreements
Ikena Oncology, Inc.
Pharmaceuticals
CA
2025
Severance Rights Agreement between Inmagene Biopharmaceuticals and Jonathan Jian Wang
Severance Agreements
Ikena Oncology, Inc.
Pharmaceuticals
CA
2025
Theravance Biopharma, Inc. Executive Severance Plan and Summary Plan Description (Amended and Restated as of November 13, 2024)
Severance Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2025
Johnson & Johnson Executive Officer Cash Severance Policy
Severance Agreements
Johnson & Johnson
Pharmaceuticals
2025
Severance Agreement and General Release between EyePoint Pharmaceuticals, Inc. and Nancy S. Lurker
Severance Agreements
EyePoint Pharmaceuticals, Inc.
Pharmaceuticals
MA
2024
Separation and Severance Agreement between Ocular Therapeutix, Inc. and Dr. Rabia Gurses Ozden
Severance Agreements
OCULAR THERAPEUTIX, INC
Pharmaceuticals
MA
2024
Separation and Severance Agreement between Ocular Therapeutics, Inc. and Antony C. Mattessich (May 2024)
Severance Agreements
OCULAR THERAPEUTIX, INC
Pharmaceuticals
MA
2024
General Release and Severance Agreement between Teofilo Raad and Pulmatrix, Inc. dated July 19, 2024
Severance Agreements
Pulmatrix, Inc.
Pharmaceuticals
MA
2024
General Release and Severance Agreement between Chris Chapman, M.D. and MyMD Pharmaceuticals, Inc.
Severance Agreements
Akers Biosciences, Inc.
Pharmaceuticals
MD
2024
Liquidia Corporation Amended and Restated Executive Severance and Change in Control Plan (May 2024)
Severance Agreements
Liquidia Corp
Pharmaceuticals
DE
2024
Merck & Co., Inc. U.S. Separation Benefits Plan (Amended and Restated as of January 1, 2019)
Severance Agreements
Merck
Pharmaceuticals
NJ
2024
Organon & Co. Executive Separation Agreement and General Release
Severance Agreements
Organon & Co.
Pharmaceuticals
2024
Organon Executive Severance Program Amended and Restated as of February 8, 2024
Severance Agreements
Organon & Co.
Pharmaceuticals
2024
Revance Therapeutics, Inc. Executive Severance Benefit Plan (Amended and Restated as of February 7, 2024)
Severance Agreements
Revance Therapeutics, Inc.
Pharmaceuticals
CA
2024
Catalent Pharma Solutions, Inc. Executive Severance Benefits Letter Agreement
Severance Agreements
Catalent Inc
Pharmaceuticals
2023
Catalent Pharma Solutions Executive Severance Benefits Letter Agreement
Severance Agreements
Catalent Inc
Pharmaceuticals
NJ
2023
Separation and Release Agreement between Theseus Pharmaceuticals, Inc. and David Kerstein
Severance Agreements
Theseus Pharmaceuticals, Inc.
Pharmaceuticals
MA
2023
Separation and Release Agreement between Theseus Pharmaceuticals, Inc. and Tim Clackson
Severance Agreements
Theseus Pharmaceuticals, Inc.
Pharmaceuticals
MA
2023
Rain Oncology Inc. Amended and Restated Executive Severance Plan (2023)
Severance Agreements
Rain Therapeutics Inc.
Pharmaceuticals
CA
2023
Pfizer Inc. Executive Officer Cash Severance Policy
Severance Agreements
Pfizer
Pharmaceuticals
2023
Severance Agreement between Landos Biopharma, Inc. and Fabio Cataldi
Severance Agreements
Landos Biopharma, Inc.
Pharmaceuticals
MA
2023
Severance Agreement and Release between Nancy Huber and Medicine Man Technologies, Inc.
Severance Agreements
Medicine Man Technologies, Inc.
Pharmaceuticals
CO
2023
Merck & Co., Inc. U.S. Separation Benefits Plan (Amended and Restated as of January 1, 2019)
Severance Agreements
Merck
Pharmaceuticals
NJ
2023
Amendment No. 4 to the Pfizer Inc. Executive Severance Plan
Severance Agreements
Pfizer
Pharmaceuticals
2023
Severance and Settlement Agreement and Release of All Claims between Michael J. Valentino and PLx Pharma Inc.
Severance Agreements
PLx Pharma Inc.
Pharmaceuticals
2023
Severance Agreement and General Release between Liquidia Technologies, Inc. and Tushar Shah, M.D.
Severance Agreements
Liquidia Corp
Pharmaceuticals
NC
2022
Ventyx Biosciences, Inc. Executive Change in Control and Severance Plan and Summary Plan Description
Severance Agreements
Ventyx Biosciences, Inc.
Pharmaceuticals
CA
2022
Angion Biomedica Corp. Executive Separation Benefits Plan (Amended and Restated November 19, 2021)
Severance Agreements
Angion Biomedica Corp.
Pharmaceuticals
CA
2022
AN2 Therapeutics, Inc. Severance and Change in Control Plan and Summary Plan Description
Severance Agreements
AN2 Therapeutics, Inc.
Pharmaceuticals
DE
2022
Severance and General Release Agreement between Petros Pharmaceuticals, Inc. and Andrew Gesek
Severance Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2022
Cara Therapeutics, Inc. Severance Plan and Summary Plan Description (Approved October 28, 2021)
Severance Agreements
Cara Therapeutics, Inc.
Pharmaceuticals
CT
2022
Severance Agreement and General Release between Aclaris Therapeutics, Inc. and David Gordon
Severance Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2022
Severance Agreement and General Release between Aclaris Therapeutics, Inc. and Employee (November 2021)
Severance Agreements
Aclaris Therapeutics, Inc.
Pharmaceuticals
PA
2022
Severance and Change in Control Agreement between Corcept Therapeutics Incorporated and William Guyer
Severance Agreements
Corcept Therapeutics Incorporated
Pharmaceuticals
CA
2022
Severance Protection Letter Agreement between Phibro Animal Health Corporation and Damian Finio
Severance Agreements
Phibro Animal Health Corporation
Pharmaceuticals
DE
2022
First Amendment to Employment Letter Agreement between Imara Inc. and Michael Gray
Severance Agreements
IMARA Inc.
Pharmaceuticals
2021
Mallinckrodt Pharmaceuticals Severance Plan for U.S. Officers and Executives (Amended September 8, 2021)
Severance Agreements
Mallinckrodt
Pharmaceuticals
2021